Technology & Devices

New Peer-Reviewed Study Finds That Doctor On Demand Video Visits Foster Physician-Patient Relationships and Drive Patient Satisfaction

SAN FRANCISCO–(BUSINESS WIRE)–A new study published in the June issue of Mayo Clinic Proceedings suggests that patients who used Doctor On Demand’s video-based telemedicine visits appreciate their relationships with the physician and overall user experience, including access and convenience. Further, this study found that the majority of patients who interacted …

Read More »

Microsoft and Adaptive Launch ImmuneCODE Database to Share Populationwide Immune Response to COVID-19

SEATTLE and REDMOND, Wash., June 11, 2020 /PRNewswire/ — Adaptive Biotechnologies Corp. (Nasdaq: ADPT) on Thursday launched ImmuneCODE with Microsoft Corp. (Nasdaq: MSFT) to begin sharing one of the largest, most detailed views of the immune response to COVID-19 in real time based on de-identified data generated from thousands of …

Read More »

Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Illumina COVIDSeq™ Test, a high-throughput, sequencing-based, in vitro diagnostic (IVD) workflow enabling the detection of SARS-CoV-2. The …

Read More »

Thermo Fisher Scientific to Co-Develop a Global Companion Diagnostic for Low-Grade Glioma with Agios Pharmaceuticals

CARLSBAD, Calif., June 9, 2020 /PRNewswire/ — Thermo Fisher Scientific today announced that it has expanded its strategic partnership with Agios Pharmaceuticals by adding the co-development of a second companion diagnostic (CDx) for oncology to their existing agreement. The CDx will leverage the Oncomine Precision Assay, which runs on the …

Read More »

FDA Grants Emergency Use Authorization to Roche’s Elecsys IL-6 Test to Identify Patients at High Risk of Severe Inflammatory Response

Basel, 04 June 2020  – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Elecsys® IL-6 test. This test measures levels of the biomarker interleukin 6 (IL-6) and can be used to help identify …

Read More »

Siemens Healthineers Receives FDA Emergency Use Authorization for its SARS-CoV-2 Total Antibody Test that Delivers Superior Clinical Performance

TARRYTOWN, N.Y.–(BUSINESS WIRE)–Siemens Healthineers announced today the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its laboratory-based total antibody test to detect the presence of SARS-CoV-2 antibodies including IgM and IgG in blood. Test data demonstrated 100 percent sensitivity2 and 99.8 percent specificity. The total antibody …

Read More »

ArcherDX and AstraZeneca Collaborate to Develop Personalized Cancer Monitoring Assays for Minimal Residual Disease

BOULDER, Colo., May 26, 2020 /PRNewswire/ — ArcherDX, Inc., today announced a strategic collaboration with AstraZeneca to develop assays to support multiple planned Phase 3 clinical trials for AstraZeneca’s targeted immuno-oncology therapeutics. Under the terms of the agreement, ArcherDX will perform Whole Exome Sequencing (WES) of resected non-small cell lung …

Read More »

Tavotek Enters Research Agreement with Genmab for Development of Bispecific Antibodies Using Genmab’s DuoBody Platform Against a Pair of Disease Relevant Targets

AMBLER, Pa., May 25, 2020 /PRNewswire/ — Tavotek Biotherapeutics, a biotech company which develops novel biologics for autoimmune diseases and oncology, announced that it has entered into a research agreement with Genmab A/S of Denmark to create and develop bispecific antibodies using Genmab’s DuoBody® technology platform against disease relevant target …

Read More »

Roche Acquires Stratos Genomics to Further Develop DNA Based Sequencing for Diagnostic Use

Basel, 22 May 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche’s nanopore sequencer. The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX™). The Roche nanopore sequencer, …

Read More »

ArcherDX Receives FDA Breakthrough Device Designation for its NGS Device Under Development as a CDx to Detect NTRK Gene Fusions

BOULDER, Colo., May 19, 2020 /PRNewswire/ — ArcherDX, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its next-generation sequencing (NGS) device under development as a companion diagnostic (CDx) to detect neurotrophic receptor tyrosine kinase (NTRK) gene fusions that lead to the …

Read More »